Slide 1Bundesinstitut für Arzneimittel und Medizinprodukte Pt WHO-consultant 1 World Health Organization Training Workshop on Pharmaceutical Quality, Good Manufacturing…

Slide 1Kiev, 04/12/2007 Analysis of EU MRP/DCP procedures regarding to generic applications Dr.Raimonds Lozda, FMS Baltic Ltd Slide 2 Kiev, 04/12/2007 EU Authorities National…

1. Second and further medical use patents: enforcement perspectiveDr Duncan Curley Director and Head of Patents, Innovate Legal C5 Pharma & Biotech Patent Litigation…

Bruno Flamion, MD, PhD University of Namur Namur, Belgium NDA Advisory Group Past Chair of the European Medicines Agency (EMA) Scientific Advice Group Regulatory perspectives…

Slide 1 Fordham IP Conference 9 April, 2015 - Cambridge Biosimilar Patent Litigation – UK Perspective Dr Penny Gilbert Powell Gilbert LLP 1 Slide 2 A changing landscape.…

Slide 1 Data protection and extension of patent rights TRIPS requirements & TRIPS-plus provisions Carlos Correa Slide 2  Test data protection Slide 3 Medicines are…

Implementation of Bioequivalence Study for Generic Medicines in Malaysia Centre For Product Registration National Pharmaceutical Control Bureau (NPCB) Ministry of Health…